Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
| Role | Insider | Date | Transaction | Value | Shares |
|---|---|---|---|---|---|
| Director | Aghazadeh Behzad | Jul 28, 2026 | Buy | $144.27K | 7,905 |
| Director | ORBIMED ADVISORS LLC | Jul 27, 2026 | Buy | $15M | 1,000,000 |
| Director | GORDON CARL L | Jul 27, 2026 | Buy | $15M | 1,000,000 |
| 10% Owner | AH Bio Fund II, L.P. | Jul 27, 2026 | Buy | $5M | 333,333 |
| Director | Aghazadeh Behzad | Jul 24, 2026 | Buy | $35M | 2,333,333 |
| Director | Aghazadeh Behzad | Jul 24, 2026 | Buy | $1.12M | 50,000 |
| CFO | Parrot David | Jul 23, 2026 | Buy | $20K | 1,333 |
| Chief Business Officer | Lucas Svetlana | Jul 23, 2026 | Buy | $45K | 3,000 |
| CFO | Parrot David | Jul 23, 2026 | Buy | $20K | 1,333 |
Open-market purchases and sales reported on SEC form 4 over the last 10years. Awards, option exercises, gifts and other non-market form 4 activity are excluded. Chart markers group a day's filings by direction; the table lists each filing.